FDA Inspection
Cleveland Clinic Mercy HospitalCleveland Clinic Mercy Hospital – FDA Inspection, Nov 30, 2012
Record Details
This FDA Inspection record concerns Cleveland Clinic Mercy Hospital, with an inspection on November 30, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- November 30, 2012
- Product Type
- Biologics
View Company Profile
ID · 2da39dde-e85f-4f22-80cf-32062762a519
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 808837
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cleveland Clinic Mercy Hospital
7| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 17, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 11, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 25, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 21, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Cleveland Clinic Mercy Hospital
- FDA Inspection 1238101 - 2024-04-25
- FDA Inspection 1163363 - 2022-02-17
- FDA Inspection 1070001 - 2018-10-11
- FDA Inspection 988944 - 2016-10-25
- FDA Inspection 900582 - 2014-10-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.